← 產業報告目錄

Nutraceutical Gummies Market by Type (B2B, B2C), Product Type (Vitamins, Minerals, Omega-3 Fatty Acids), Consumer Type, Production Capacity, Ingredient Source, Functionality, Demographics, Sales Channel, and Region – Global Forecast to 2030

出版商 MarketsandMarkets產業別 Food & Beverage出版日期 2026-02-04頁數 529報告編號 FB10204

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The nutraceutical gummies market is estimated at USD 24.39 billion in 2025 and is projected to reach USD 47.80 billion by 2030, at a CAGR of 14.4%. The global nutraceutical gummies market is experiencing significant growth, driven by rising rates of vitamin deficiency and undernutrition, a growing focus on preventive health and wellness, rising consumer interest in beauty and wellness, expanding e-commerce and DTC channels, and an increasing preference for the gummy delivery format over traditional pills and capsules. Additionally, growth in plant-based and sugar-free gummies, increasing reliance of startups and D2C brands on turnkey contract manufacturing, and geographic expansion with localized formulation expertise are expected to create significant opportunities in the nutraceutical gummies market. However, high production costs and ingredient stability issues, regulatory complexities across regions, and the complexity of maintaining batch-to-batch consistency and stability are expected to pose challenges in the nutraceutical gummies market. Furthermore, increasing audit expectations from global brand owners and intense market competition and brand differentiation also remain technical challenges. “Immunity support function is expected to hold a dominant market share during the forecast period.” The popularity of nutraceutical gummies is growing because of their convenient form, size, and ease of consumption. The benefits of multivitamin gummies for boosting immunity also play a key role in the increased demand for nutraceutical gummies. Gummies offer the fastest growth potential for vitamin and mineral supplements. The market for immunity-specific gummy supplements is expected to grow as more people become aware of how nutrition affects their health and of the specific issues that can be addressed through lifestyle factors. “The online channel segment in the B2C segment is expected to hold a significant market share among the sales channels in the nutraceutical gummies market.” With rising awareness, demand, and traction, nutraceutical gummies have become a mainstream market staple. The increase in demand for these products has led to a rise in sales across various countries and regions, facilitated by both online and offline distribution channels. Key players are increasingly adopting and navigating their investments in distribution channels to make their products available to a wider consumer base. In addition, nutraceutical gummies manufacturing companies are promoting their products in the market through strategies such as online retailing, a part of the non-store-based distribution channel, which is expected to drive demand. “Europe is expected to hold a significant share in the global nutraceutical gummies market during the forecast period.” Companies operating in this region are also investing in expansions and acquisitions to meet the growing demand from the dietary supplements industry, including nutraceutical gummies. The growing demand for nutraceutical gummies in Europe is attributed to fast-paced lifestyles, health-conscious consumers, and urbanization. In 2020, Unilever acquired SmartyPants Vitamins, a US-based vitamin, mineral & supplement company. SmartyPants utilizes a range of sustainably sourced, bioavailable nutrients and non-GMO-certified ingredients. Its product line is free of artificial preservatives, sweeteners, colors, and flavors. This has made Unilever expand its product portfolio and serve more consumers in Europe. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical gummies market. • By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30% • By Designation: CXOs – 25%, Managers – 40%, Others – 35% • By Region: North America – 25%, Europe – 25%, Asia Pacific – 35%, South America – 10%, and Rest of the World –5% Prominent companies in the market include—Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestlé (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. ( US), Activ'Inside ( France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US) among others. Research Coverage This research report categorizes the nutraceutical gummies market by type (B2B market and B2C market); customer type (B2B) (brand owners and marketing companies, retailers and distributors, healthcare and wellness providers, pharmaceutical companies, and food & beverage companies); production capacity (B2B) (small-scale contract manufacturers (< 10 m units/year), mid-scale manufacturers (10–50 m units/year), and large-scale industrial manufacturers (50 m+ units/year)); ingredient source (B2B) (animal-based source, plant-based source, microbial/fermentation-derived sources, and synthetic/chemically-derived sources); gummy base/excipients (B2B) (gelatin-based gummies, pectin-based gummies, starch-based gummies, agar, carrageenan, and other hydrocolloids); product type (B2C) (vitamins, minerals, omega-3 fatty acids, probiotics and prebiotics, collagen and beauty-from-within, herbal and botanical supplements, dietary fiber, CBD and cannabis-derived, and specialty formulations); functionality (B2C) (immunity support, general health & wellness, bone & joint health, weight management, beauty & skin health, and other functionalities); demographics (B2C) (generation alpha (0–12 years), generation Z (13–28 years), millennials (gen Y) (29–44 years), generation X (45–60 years), and baby boomers & older (61+ years)); sales channel (offline and online); and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical gummies industry. A thorough analysis of key industry players has been conducted to provide insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the nutraceutical gummies market. This report provides a competitive analysis of emerging startups in the nutraceutical gummies market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others. Reasons to Buy This Report The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical gummies and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (increasing preference for gummy delivery format over traditional pills and capsules, driving production volume), restraints (ingredient sourcing volatility), opportunities (increasing reliance of startups and D2C brands on turnkey contract manufacturing), and challenges (increasing audit expectations from global brand owners), influencing the growth of the nutraceutical gummies market • Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical gummies market • Market Development: Comprehensive information about lucrative markets—analysis of nutraceutical gummies across varied regions • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the nutraceutical gummies market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestlé (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature’s Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. (US), Activ'Inside (France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among other players in the nutraceutical gummies market.
目錄 Table of Contents
1 INTRODUCTION 49 1.1 STUDY OBJECTIVES 49 1.2 MARKET DEFINITION 49 1.2.1 INCLUSIONS AND EXCLUSIONS 50 1.3 STUDY SCOPE 52 1.4 YEARS CONSIDERED 53 1.5 CURRENCY CONSIDERED 53 1.6 UNIT CONSIDERED 54 1.7 STAKEHOLDERS 54 2 EXECUTIVE SUMMARY 55 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 55 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 57 2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL GUMMIES MARKET 58 2.4 HIGH GROWTH SEGMENTS 59 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 60 3 PREMIUM INSIGHTS 61 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET 61 3.2 B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY AND REGION 62 3.3 B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE AND REGION 63 3.4 B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE 63 3.5 B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE 64 3.6 B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS 64 3.7 B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY 65 3.8 B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY 65 4 MARKET OVERVIEW 66 4.1 INTRODUCTION 66 4.2 MARKET DYNAMICS 67 4.2.1 DRIVERS 67 4.2.1.1 Rising rate of vitamin-deficiency diseases and undernutrition 67 4.2.1.2 Growing consumer interest in beauty and wellness 68 4.2.1.3 Innovation in functional formulations 69 4.2.1.4 Growth in gummy supplement launches and custom gummy programs 70 4.2.1.5 Increasing preference for gummy delivery format over traditional pills and capsules 70   4.2.2 RESTRAINTS 71 4.2.2.1 Regulatory complexities across regions 71 4.2.2.2 Sugar content and health concerns 71 4.2.2.3 Ingredient sourcing volatility 72 4.2.2.4 Complexity in maintaining batch-to-batch consistency and stability 72 4.2.3 OPPORTUNITIES 72 4.2.3.1 Rising popularity of plant-based and sugar-free gummies 72 4.2.3.2 Expansion into personalized and AI-driven nutrition 73 4.2.3.3 Increasing reliance of startups and D2C brands on turnkey contract manufacturing 73 4.2.3.4 Geographic expansion with localized formulation expertise 74 4.2.4 CHALLENGES 74 4.2.4.1 Limited bioavailability and nutrient degradation 74 4.2.4.2 Intense market competition and brand differentiation 75 4.2.4.3 Logistics issues: Melting, deformation, and transit stability 75 4.2.4.4 Increasing audit expectations from global brand owners 75 4.3 UNMET NEEDS AND WHITE SPACES 76 4.3.1 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET 76 4.3.2 WHITE SPACE OPPORTUNITIES 77 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 78 4.4.1 INTERCONNECTED MARKETS 78 4.4.2 CROSS-SECTOR OPPORTUNITIES 79 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 80 4.5.1 KEY MOVES AND STRATEGIC FOCUS 80 5 INDUSTRY TRENDS 81 5.1 PORTER’S FIVE FORCES ANALYSIS 81 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 82 5.1.2 BARGAINING POWER OF SUPPLIERS 82 5.1.3 BARGAINING POWER OF BUYERS 82 5.1.4 THREAT OF SUBSTITUTES 82 5.1.5 THREAT OF NEW ENTRANTS 82 5.2 MACROECONOMICS OUTLOOK 83 5.2.1 INTRODUCTION 83 5.2.1.1 Macroeconomic indicators - B2C market 83 5.2.1.1.1 US-China trade tariff fluctuations reshape nutraceutical gummies market 83 5.2.1.1.2 Inflation and raw material costs reshape nutraceutical gummies market 84 5.2.1.1.2.1 Sweeteners and sugar inputs 84 5.2.1.1.2.2 Gelling agents: Gelatin, pectin, and alternatives 84 5.2.1.1.2.3 Vitamins, actives, flavors, and specialty additives 84 5.2.1.1.2.4 Energy, transportation, and packaging inflation 85 5.2.1.2 Macroeconomic indicators - B2B market 85 5.2.1.2.1 Population aging and chronic disease burden influencing preventive health and nutraceutical market expansion 85 5.3 VALUE CHAIN ANALYSIS 86 5.3.1 RAW MATERIAL & FUNCTIONAL INGREDIENT SOURCING 87 5.3.2 PRODUCT DEVELOPMENT AND MANUFACTURING 88 5.3.3 QUALITY, SAFETY, AND REGULATORY COMPLIANCE 88 5.3.4 PACKAGING & LABEL CUSTOMIZATION 89 5.3.5 MARKETING AND DISTRIBUTION 89 5.3.6 END USERS 89 5.4 ECOSYSTEM ANALYSIS 89 5.4.1 DEMAND SIDE 89 5.4.2 SUPPLY SIDE 90 5.5 PRICING ANALYSIS 91 5.5.1 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER 91 5.5.2 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION 94 5.6 TRADE ANALYSIS 96 5.6.1 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT) 96 5.6.2 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT) 96 5.7 KEY CONFERENCES AND EVENTS, 2026–2027 98 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 99 5.9 INVESTMENT AND FUNDING SCENARIO 99 5.10 CASE STUDY ANALYSIS 100 5.10.1 NESTLÉ HEALTH SCIENCE – EXPANDED COLLAGEN & FUNCTIONAL PORTFOLIO THROUGH MAJORITY STAKE ACQUISITION OF VITAL PROTEINS 100 5.10.2 SIRIO PHARMA – EXPANDING NUTRACEUTICAL GUMMY AND PLANT-BASED SOFTGEL MANUFACTURING THROUGH ACQUISITION OF BEST FORMULATIONS 100 5.10.3 TOPGUM INDUSTRIES – EXPANDING PHARMA GRADE AND HIGH VOLUME GUMMY MANUFACTURING THROUGH ACQUISITION OF ISLAND ABBEY NUTRITIONALS 101 5.10.4 GILLCO/IFF GRINDSTED – ENHANCING GUMMY GELATION AND PROCESS STABILITY USING SLOW-SET PECTIN 102 5.11 IMPACT OF 2025 US TARIFF – NUTRACEUTICAL GUMMIES MARKET 102 5.11.1 INTRODUCTION 102 5.11.2 KEY TARIFF RATES 103 5.11.3 PRICE IMPACT ANALYSIS 104 5.11.4 IMPACT ON COUNTRIES/REGIONS 104 5.11.4.1 US 104 5.11.4.2 Europe 105 5.11.4.3 Asia Pacific 105 5.11.5 IMPACT ON END-USE INDUSTRIES 105 6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 107 6.1 TECHNOLOGY ANALYSIS 107 6.1.1 KEY TECHNOLOGIES 107 6.1.1.1 Gelling and texture technology 107 6.1.1.1.1 Starch-based gelling technology 108 6.1.1.1.2 Starchless gelling technology 108 6.1.1.2 Microencapsulation technology (taste masking & flavor) 108 6.1.2 COMPLEMENTARY TECHNOLOGIES 109 6.1.2.1 Coating technology 109 6.1.2.2 Nutrient stabilization methods 109 6.1.2.3 Flavor release systems 110 6.1.3 ADJACENT TECHNOLOGIES 110 6.1.3.1 3D-printing & personalized dosing platforms 110 6.1.3.2 Plant-based and clean-label ingredient technologies 110 6.1.3.3 Smart packaging 111 6.2 TECHNOLOGY/PRODUCT ROADMAP 111 6.2.1 SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION 111 6.2.2 MID-TERM | EXPANSION & STANDARDIZATION 112 6.2.3 LONG-TERM | PRECISION NUTRITION & SMART CALCIUM SOLUTIONS 112 6.3 PATENT ANALYSIS 112 6.4 FUTURE APPLICATIONS 114 6.4.1 GELATIN-FREE, REDUCED-SUGAR FUNCTIONAL GUMMIES ENRICHED WITH PGH EXTRACT 114 6.4.2 MICROENCAPSULATION OF VITAMIN C FOR IMPROVED STABILITY IN NUTRACEUTICAL GUMMIES 115 6.4.3 3D-PRINTED PATIENT-TAILORED MEDICINAL GUMMIES FOR PEDIATRIC DRUG DELIVERY 115 6.4.4 EDIBLE ACTIVE PACKAGING AS SMART PACKAGING FOR NUTRACEUTICAL GUMMIES 116 6.4.5 IOT-ENABLED SMART MANUFACTURING AND ITS FUTURE APPLICATION IN NUTRACEUTICAL GUMMY PRODUCTION 117 6.5 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 117 6.5.1 INTRODUCTION 117 6.5.2 USE OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 118 6.5.3 TOP USE CASES AND MARKET POTENTIAL 118 6.5.4 BEST PRACTICES IN NUTRACEUTICAL INDUSTRY 119 6.5.5 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL GUMMIES MARKET 119 6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 120 6.5.7 CLIENTS’ READINESS TO ADOPT GENERATIVE AI NUTRACEUTICAL GUMMIES 120 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 121 7.1 REGIONAL REGULATIONS AND COMPLIANCE 121 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121 7.1.2 INDUSTRY STANDARDS 123 7.1.3 LABELING REQUIREMENTS AND CLAIMS 124 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5–10 YEARS 125 7.1.4.1 Mandatory validation of bioavailability & functional claims 125 7.1.4.2 Global harmonization of dietary supplement & nutraceutical classifications 125 7.1.4.3 Strengthened safety, contaminant, & additive control regulations 125 7.1.4.4 Digital labeling, traceability & QR-based compliance tracking 125 7.2 SUSTAINABILITY INITIATIVES 126 7.2.1 SUSTAINABLE SOURCING 126 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 126 7.2.3 CIRCULAR ECONOMY APPROACHES 127 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 128 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 129 8.1 DECISION-MAKING PROCESS 129 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 130 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 130 8.2.2 BUYING CRITERIA 131 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 132 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 133 8.5 MARKET PROFITABILITY 134 8.6 REVENUE POTENTIAL 134 8.6.1 COST DYNAMICS 135 8.6.2 MARGIN OPPORTUNITIES, BY TYPE 136 9 NUTRACEUTICAL GUMMIES MARKET, BY TYPE 137 9.1 INTRODUCTION 138 9.2 B2C MARKET 139 9.2.1 ADVANCING CONSUMER HEALTH THROUGH FUNCTIONAL GUMMIES 139 9.3 B2B MARKET 139 9.3.1 POWERING BRANDS WITH SCALABLE, SCIENCE-DRIVEN GUMMY SOLUTIONS 139 10 NUTRACEUTICAL GUMMIES MARKET (B2B), BY CUSTOMER TYPE 140 10.1 INTRODUCTION 141 10.2 BRAND OWNERS & MARKETING COMPANIES 142 10.2.1 DEMAND FOR DIFFERENTIATED, CLEAN-LABEL, AND TREND-RESPONSIVE GUMMY FORMULATIONS TO BENEFIT CONTRACT MANUFACTURERS AND PRIVATE-LABEL PARTNERS 142 10.3 RETAILERS & DISTRIBUTORS 145 10.3.1 RAPID EXPANSION OF PRIVATE-LABEL SUPPLEMENTS AND OMNICHANNEL RETAIL STRATEGIES TO INCREASE RETAILER DEMAND FOR COST-EFFICIENT, HIGH-QUALITY GUMMY MANUFACTURING PARTNERSHIPS 145 10.4 HEALTHCARE & WELLNESS 147 10.4.1 GROWING INTEGRATION OF NUTRITION INTO PREVENTIVE CARE, PEDIATRICS, AND WELLNESS PROGRAMS TO DRIVE DEMAND FOR CLINICALLY CREDIBLE, COMPLIANCE-FRIENDLY GUMMY SUPPLEMENTS 147 10.5 PHARMACEUTICAL COMPANIES 149 10.5.1 PHARMACEUTICAL PLAYERS LEVERAGE NUTRACEUTICAL GUMMIES TO EXTEND CONSUMER HEALTH PORTFOLIOS BEYOND PRESCRIPTIONS WHILE MAINTAINING CLINICAL CREDIBILITY AND QUALITY DIFFERENTIATION 149 10.6 FOOD & BEVERAGE COMPANIES 151 10.6.1 CONVERGENCE OF INDULGENCE AND FUNCTIONALITY PROMPTING CONFECTIONERY AND FOOD COMPANIES TO EXPLORE FUNCTIONAL GUMMIES 151 11 NUTRACEUTICAL GUMMIES MARKET (B2B), BY PRODUCTION CAPACITY 154 11.1 INTRODUCTION 155 11.2 SMALL-SCALE CONTRACT MANUFACTURERS (<10 M UNITS/YEAR) 156 11.2.1 GROWING DEMAND FOR LOW-VOLUME, CUSTOMIZED GUMMY FORMULATIONS TO SUPPORT EMERGING NUTRACEUTICAL BRANDS 156 11.3 MID-SCALE MANUFACTURERS (10–50 M UNITS/YEAR) 157 11.3.1 INCREASING NEED FOR SCALABLE PRODUCTION WITH FORMULATION FLEXIBILITY TO SUPPORT BRAND EXPANSION AND REGIONAL MARKET PENETRATION 157 11.4 LARGE-SCALE INDUSTRIAL MANUFACTURERS (50+ M UNITS/YEAR) 159 11.4.1 RISING REQUIREMENT FOR HIGH-VOLUME, STANDARDIZED GUMMY PRODUCTION TO ENSURE SUPPLY CONSISTENCY FOR GLOBAL NUTRACEUTICAL BRANDS 159 12 NUTRACEUTICAL GUMMIES MARKET (B2B), BY INGREDIENT SOURCE 161 12.1 INTRODUCTION 162 12.2 ANIMAL-BASED SOURCES 163 12.2.1 COLLAGEN EFFICACY KEEPS ANIMAL-BASED INGREDIENTS DOMINANT 163 12.3 PLANT-BASED SOURCES 165 12.3.1 VEGAN AND CLEAN-LABEL DEMAND FUELS PLANT-BASED ADOPTION 165 12.4 MICROBIAL/FERMENTATION-DERIVED SOURCES 167 12.4.1 ADVANCEMENTS IN STABILIZED FERMENTATION TECHNOLOGIES TO EXPANDING ADOPTION OF MICROBIAL-DERIVED ACTIVES IN GUMMY FORMULATIONS 167 12.5 SYNTHETIC/CHEMICALLY-DERIVED SOURCES 169 12.5.1 CONSISTENCY AND SCALE TO SUSTAIN SYNTHETIC INGREDIENT USAGE 169 13 NUTRACEUTICAL GUMMIES MARKET (B2B), BY GUMMY BASE/EXCIPIENTS 172 13.1 INTRODUCTION 173 13.2 GELATIN-BASED GUMMIES 174 13.2.1 HIGH ACTIVE LOADING AND TEXTURE RELIABILITY TO CONTINUE DRIVING GELATIN USAGE 174 13.3 PECTIN-BASED GUMMIES 175 13.3.1 VEGAN POSITIONING AND CLEAN-LABEL DEMAND TO ACCELERATE PECTIN ADOPTION 175 13.4 STARCH-BASED GUMMIES 176 13.4.1 COST PRESSURE AND LARGE-SCALE PRODUCTION NEEDS TO SUSTAIN STARCH-BASED SYSTEMS 176 13.5 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS 177 14 NUTRACEUTICAL GUMMIES MARKET (B2C), BY PRODUCT TYPE 179 14.1 INTRODUCTION 180 14.2 VITAMINS 181 14.2.1 RISING INSTANCES OF VITAMIN DEFICIENCIES TO DRIVE SEGMENT 181 14.2.2 MULTIVITAMINS 183 14.2.3 VITAMIN C 184 14.2.4 VITAMIN D 185 14.2.5 VITAMIN B COMPLEX 186 14.2.6 VITAMIN E AND A 187 14.3 MINERALS 189 14.3.1 MEETING ESSENTIAL MINERAL NEEDS THROUGH CONVENIENT, PALATABLE SUPPLEMENTATION FOR EVERYDAY HEALTH SUPPORT 189 14.3.2 CALCIUM 191 14.3.3 IRON 191 14.3.4 ZINC 192 14.3.5 MAGNESIUM 193 14.4 OMEGA-3 FATTY ACIDS 194 14.5 PROBIOTICS & PREBIOTICS 196 14.5.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET 196 14.6 COLLAGEN & BEAUTY-FROM-WITHIN 197 14.6.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET 197 14.7 HERBAL & BOTANICAL 199 14.7.1 RISING CONSUMER PREFERENCE FOR PLANT-BASED NATURAL INGREDIENTS TO DRIVE SEGMENT 199 14.7.2 ASHWAGANDHA 201 14.7.3 TURMERIC/CURCUMIN 202 14.7.4 ELDERBERRY 203 14.7.5 MELATONIN 204 14.7.6 OTHER HERBAL AND BOTANICAL GUMMIES 205 14.8 DIETARY FIBER 205 14.9 CBD & CANNABIS-DERIVED 206 14.10 SPECIALTY FORMULATIONS 208 14.10.1 HEALTH-PROMOTING PROPERTIES TO AUGMENT SEGMENT GROWTH 208 15 NUTRACEUTICAL GUMMIES MARKET(B2C), BY FUNCTIONALITY 209 15.1 INTRODUCTION 210 15.2 IMMUNITY SUPPORT 211 15.2.1 RISING FOCUS ON IMPROVING IMMUNITY TO DRIVE MARKET 211 15.3 GENERAL HEALTH & WELLNESS 212 15.3.1 GROWING NUTRITIONAL DEFICIENCIES AND PREVENTIVE HEALTHCARE TRENDS TO DRIVE MARKET 212 15.4 BONE & JOINT HEALTH 213 15.4.1 RISING CASES OF OSTEOPOROSIS TO PROPEL MARKET GROWTH 213 15.5 WEIGHT MANAGEMENT 215 15.5.1 RISING PREVALENCE OF OBESITY AND METABOLIC DISORDERS TO DRIVE MARKET 215 15.6 BEAUTY & SKIN HEALTH 216 15.6.1 INCREASING FOCUS ON APPEARANCE AND OVERALL SKIN WELLNESS TO DRIVE MARKET 216 16 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DEMOGRAPHICS 219 16.1 INTRODUCTION 220 16.2 GENERATION ALPHA (0–12 YEARS) 221 16.2.1 EARLY-LIFE SUPPLEMENTATION AND DIGITAL-FIRST PARENTING TO FUEL DEMAND FOR PEDIATRIC NUTRACEUTICAL GUMMIES 221 16.3 GENERATION Z (13–28 YEARS) 222 16.3.1 FOCUS ON HEALTH AND DAILY SELF-CARE TO FUEL GUMMY SUPPLEMENT DEMAND 222 16.4 MILLENNIALS (GEN Y) (29–44 YEARS) 224 16.4.1 LIFESTYLE-DRIVEN WELLNESS CHOICES TO POWER NUTRACEUTICAL ADOPTION 224 16.5 GENERATION X (45–60 YEARS) 225 16.5.1 WILLINGNESS TO INVEST IN HEALTH-ENHANCING NUTRITION SOLUTIONS TO DRIVE MARKET 225 16.6 BABY BOOMERS AND OLDER (61+ YEARS) 226 16.6.1 HEALTHY AGING PRIORITIES TO DRIVE NUTRACEUTICAL USE 226 17 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DISTRIBUTION CHANNEL 228 17.1 INTRODUCTION 229 17.2 OFFLINE CHANNELS 230 17.2.1 HYPERMARKETS & SUPERMARKETS 232 17.2.1.1 Preferred purchasing destination and availability of variants to drive growth 232 17.2.2 PHARMACIES & DRUGSTORES 233 17.2.2.1 Wide presence and around-the-clock services to drive growth 233 17.2.3 SPECIALTY HEALTH STORES 234 17.2.3.1 Enabling premium and targeted gummy supplement sales 234 17.2.4 CONVENIENCE STORES 235 17.2.4.1 Preference toward specialized healthcare products to fuel growth 235 17.2.5 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM) 236 17.2.5.1 High-volume retail and network-based selling drive offline expansion 236 17.3 ONLINE CHANNELS 237 18 NUTRACEUTICAL GUMMIES MARKET, BY REGION 239 18.1 INTRODUCTION 240 18.2 NORTH AMERICA 244 18.2.1 US 264 18.2.1.1 Presence of key players and various health trends to boost market 264 18.2.2 CANADA 267 18.2.2.1 Convenience, taste, and health benefits to drive demand for nutraceutical gummies 267 18.2.3 MEXICO 269 18.2.3.1 Rising health-conscious and vegan population to drive market 269 18.3 EUROPE 271 18.3.1 GERMANY 291 18.3.1.1 Growing interest in health & wellness to drive market 291 18.3.2 UK 293 18.3.2.1 Rising prevalence of diseases to drive market 293 18.3.3 FRANCE 296 18.3.3.1 High healthcare costs and increased demand for dietary supplements to drive market 296 18.3.4 SPAIN 298 18.3.4.1 Adoption of healthy lifestyles to drive market 298 18.3.5 ITALY 301 18.3.5.1 Strong e-commerce system and rising geriatric population to drive market 301 18.3.6 REST OF EUROPE 303 18.4 ASIA PACIFIC 305 18.4.1 CHINA 325 18.4.1.1 Large population and increasing prevalence of diseases to drive market 325 18.4.2 JAPAN 328 18.4.2.1 Rising awareness and shifting preferences toward dietary supplements to drive market 328 18.4.3 INDIA 330 18.4.3.1 Rising disposable incomes and growing focus on wellness to drive market 330 18.4.4 AUSTRALIA & NEW ZEALAND 333 18.4.4.1 High demand for dietary supplements, particularly in new formats, to drive market 333 18.4.5 REST OF ASIA PACIFIC 335 18.5 SOUTH AMERICA 338 18.5.1 BRAZIL 357 18.5.1.1 Increasing consumer preference for convenient and palatable formats in nutrient intake to drive market 357 18.5.2 ARGENTINA 360 18.5.2.1 Growing focus on prevention of micronutrient deficiencies and cardiometabolic risks to drive market 360 18.5.3 REST OF SOUTH AMERICA 362 18.6 REST OF THE WORLD 364 18.6.1 MIDDLE EAST 383 18.6.1.1 Rising disposable incomes and healthcare costs to drive market 383 18.6.2 AFRICA 386 18.6.2.1 Increase in vitamin deficiency and consumer awareness about health supplements to fuel market 386 19 COMPETITIVE LANDSCAPE 389 19.1 OVERVIEW 389 19.2 B2C PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2025 389 19.3 REVENUE ANALYSIS (B2C MARKET), 2022–2024 391 19.4 MARKET SHARE ANALYSIS (B2C MARKET), 2024 392 19.5 MARKET SHARE ANALYSIS (B2B MARKET), 2024 394 19.6 BRAND/PRODUCT COMPARISON 396 19.7 COMPANY EVALUATION MATRIX: B2C COMPANIES, 2024 397 19.7.1 STARS 398 19.7.2 EMERGING LEADERS 398 19.7.3 PERVASIVE PLAYERS 398 19.7.4 PARTICIPANTS 398 19.7.5 COMPANY FOOTPRINT: B2C NUTRACEUTICAL GUMMIES COMPANIES, 2024 400 19.7.5.1 Company footprint 400 19.7.5.2 Regional footprint 401 19.7.5.3 Product type footprint 402 19.7.5.4 Functionality footprint 403 19.8 COMPANY EVALUATION MATRIX: B2B COMPANIES, 2024 404 19.8.1 STARS 404 19.8.2 EMERGING LEADERS 404 19.8.3 PERVASIVE PLAYERS 404 19.8.4 PARTICIPANTS 405 19.8.5 COMPETITIVE BENCHMARKING 406 19.8.5.1 Detailed list of B2B key players 406 19.8.6 COMPETITIVE BENCHMARKING: B2B COMPANIES, 2024 407 19.8.6.1 Competitive benchmarking of key B2B companies 407 19.9 COMPANY VALUATION AND FINANCIAL METRICS 408 19.10 COMPETITIVE SCENARIO 409 19.10.1 PRODUCT LAUNCHES 409 19.10.2 DEALS 413 19.10.3 EXPANSIONS 416 19.10.4 OTHER DEVELOPMENTS 418 20 COMPANY PROFILES 419 20.1 B2C PLAYERS (BRAND MANUFACTURERS) 419 20.1.1 CHURCH & DWIGHT CO., INC. 419 20.1.1.1 Business overview 419 20.1.1.2 Products/Solutions/Services offered 420 20.1.1.3 Recent developments 421 20.1.1.3.1 Product launches 421 20.1.1.4 MnM view 422 20.1.1.4.1 Key strengths 422 20.1.1.4.2 Strategic choices 422 20.1.1.4.3 Weaknesses and competitive threats 422 20.1.2 H&H GROUP 423 20.1.2.1 Business overview 423 20.1.2.2 Products/Solutions/Services offered 424 20.1.2.3 Recent developments 425 20.1.2.3.1 Deals 425 20.1.2.3.2 Expansions 426 20.1.2.3.3 Other developments 426 20.1.2.4 MnM view 427 20.1.2.4.1 Key strengths 427 20.1.2.4.2 Strategic choices 427 20.1.2.4.3 Weaknesses and competitive threats 427 20.1.3 AMWAY 428 20.1.3.1 Business overview 428 20.1.3.2 Products/Solutions/Services offered 429 20.1.3.3 Recent developments 430 20.1.3.3.1 Product launches 430 20.1.3.3.2 Deals 431 20.1.3.4 MnM view 431 20.1.3.4.1 Key strengths 431 20.1.3.4.2 Strategic choices 431 20.1.3.4.3 Weaknesses and competitive threats 431   20.1.4 BAYER AG 432 20.1.4.1 Business overview 432 20.1.4.2 Products/Solutions/Services offered 433 20.1.4.3 Recent developments 435 20.1.4.3.1 Product launches 435 20.1.4.4 MnM view 435 20.1.4.4.1 Key strengths 435 20.1.4.4.2 Strategic choices 435 20.1.4.4.3 Weaknesses and competitive threats 435 20.1.5 HALEON GROUP OF COMPANIES 436 20.1.5.1 Business overview 436 20.1.5.2 Products/Solutions/Services offered 437 20.1.5.3 Recent developments 439 20.1.5.3.1 Product launches 439 20.1.5.3.2 Deals 440 20.1.5.3.3 Expansions 440 20.1.5.4 MnM view 440 20.1.5.4.1 Key strengths 440 20.1.5.4.2 Strategic choices 441 20.1.5.4.3 Weaknesses and competitive threats 441 20.1.6 NESTLE 442 20.1.6.1 Business overview 442 20.1.6.2 Products/Solutions/Services offered 443 20.1.6.3 Recent developments 445 20.1.6.3.1 Product launches 445 20.1.6.3.2 Deals 445 20.1.6.4 MnM view 446 20.1.6.4.1 Key strengths 446 20.1.6.4.2 Strategic choices 446 20.1.6.4.3 Weaknesses and competitive threats 446 20.1.7 UNILEVER 447 20.1.7.1 Business overview 447 20.1.7.2 Products/Solutions/Services offered 448 20.1.7.3 Recent developments 449 20.1.7.3.1 Product launches 449 20.1.7.3.2 Deals 449 20.1.7.3.3 Expansions 450 20.1.7.4 MnM view 450 20.1.7.4.1 Key strengths 450 20.1.7.4.2 Strategic choices 450 20.1.7.4.3 Weaknesses and competitive threats 450   20.1.8 OTSUKA HOLDINGS CO., LTD. 451 20.1.8.1 Business overview 451 20.1.8.2 Products/Solutions/Services offered 452 20.1.8.3 Recent developments 453 20.1.8.3.1 Product launches 453 20.1.8.3.2 Expansions 454 20.1.8.4 MnM view 454 20.1.8.4.1 Key strengths 454 20.1.8.4.2 Strategic choices 454 20.1.8.4.3 Weaknesses and competitive threats 455 20.1.9 PHARMACARE LABORATORIES 456 20.1.9.1 Business overview 456 20.1.9.2 Products/Solutions/Services offered 456 20.1.9.3 Recent developments 457 20.1.9.3.1 Expansions 457 20.1.9.4 MnM view 458 20.1.10 SWANSON 459 20.1.10.1 Business overview 459 20.1.10.2 Products/Solutions/Services offered 459 20.1.10.3 Recent developments 460 20.1.10.3.1 Product launches 460 20.1.10.4 MnM view 460 20.1.11 IM HEALTHCARE 461 20.1.11.1 Business overview 461 20.1.11.2 Products/Solutions/Services offered 461 20.1.11.3 Recent developments 462 20.1.11.4 MnM view 462 20.1.12 SMP NUTRA 463 20.1.12.1 Business overview 463 20.1.12.2 Products/Solutions/Services offered 463 20.1.12.3 Recent developments 464 20.1.12.4 MnM view 464 20.1.13 NATURE’S TRUTH 465 20.1.13.1 Business overview 465 20.1.13.2 Products/Solutions/Services offered 465 20.1.13.3 Recent developments 466 20.1.13.3.1 Other developments 466 20.1.13.4 MnM view 466 20.1.14 HERBALAND NATURALS INC. 467 20.1.14.1 Business overview 467 20.1.14.2 Products/Solutions/Services offered 467   20.1.14.3 Recent developments 468 20.1.14.4 MnM view 468 20.1.15 BOSCOGEN, INC. 469 20.1.15.1 Business overview 469 20.1.15.2 Products/Solutions/Services offered 469 20.1.15.3 Recent developments 469 20.1.15.4 MnM view 469 20.2 B2B PLAYERS (CONTRACT MANUFACTURERS) 470 20.2.1 SOFGEN PHARMA 470 20.2.1.1 Business overview 470 20.2.1.2 Products/Services/Solutions offered 471 20.2.1.3 Recent developments 472 20.2.1.3.1 Expansions 472 20.2.1.4 MnM view 473 20.2.1.4.1 Key strengths 473 20.2.1.4.2 Strategic choices 473 20.2.1.4.3 Weaknesses & competitive threats 473 20.2.2 CATALENT, INC. 474 20.2.2.1 Business overview 474 20.2.2.2 Products/Services/Solutions offered 474 20.2.2.3 Recent developments 475 20.2.2.3.1 Deals 475 20.2.2.4 MnM view 475 20.2.2.4.1 Key strengths 475 20.2.2.4.2 Strategic choices 475 20.2.2.4.3 Weaknesses & competitive threats 475 20.2.3 ACTIV'INSIDE 476 20.2.3.1 Business overview 476 20.2.3.2 Products/Services/Solutions offered 476 20.2.3.3 Recent developments 477 20.2.3.4 MnM view 477 20.2.3.4.1 Key strengths 477 20.2.3.4.2 Strategic choices 477 20.2.3.4.3 Weaknesses & competitive threats 477 20.2.4 SIRIO PHARMA CO., LTD. 478 20.2.4.1 Business overview 478 20.2.4.2 Products/Services/Solutions offered 479 20.2.4.3 Recent developments 480 20.2.4.3.1 Product launches 480 20.2.4.4 MnM view 480   20.2.5 WIN NUTRA 481 20.2.5.1 Business overview 481 20.2.5.2 Products/Services/Solutions offered 481 20.2.5.3 Recent developments 482 20.2.5.4 MnM view 482 20.2.6 MAKERS NUTRITION, LLC 483 20.2.6.1 Business overview 483 20.2.6.2 Products/Services/Solutions offered 484 20.2.6.3 Recent developments 485 20.2.6.4 MnM view 485 20.2.7 ION LABS 486 20.2.7.1 Business overview 486 20.2.7.2 Products/Services/Solutions offered 487 20.2.7.3 Recent developments 487 20.2.7.3.1 Expansions 487 20.2.7.3.2 Deals 488 20.2.7.4 MnM view 488 20.2.8 VITAJOY GROUP 489 20.2.8.1 Business overview 489 20.2.8.2 Products/Services/Solutions offered 490 20.2.8.3 Recent developments 490 20.2.8.4 MnM view 490 20.2.9 BLISS LIFESCIENCES LLP 491 20.2.9.1 Business overview 491 20.2.9.2 Products/Services/Solutions offered 491 20.2.9.3 Recent developments 492 20.2.9.4 MnM view 492 20.2.10 GLOBAL WIDGET 493 20.2.10.1 Business overview 493 20.2.10.2 Products/Services/Solutions offered 494 20.2.10.3 Recent developments 495 20.2.10.3.1 Product launches 495 20.2.10.3.2 Deals 496 20.2.10.3.3 Expansions 496 20.2.10.4 MnM view 496 20.2.11 GUMMY WORLDS 497 20.2.12 TOPGUM 498 20.2.13 MERICAL 499 20.2.14 FERMENTIS LIFE SCIENCES 500 20.2.15 EAGLE LABS, INC. 501   21 RESEARCH METHODOLOGY 502 21.1 RESEARCH DATA 502 21.1.1 SECONDARY DATA 503 21.1.1.1 Key data from secondary sources 503 21.1.2 PRIMARY DATA 504 21.1.2.1 Key industry insights 504 21.1.2.2 Breakdown of primary interviews 505 21.1.2.3 Primary sources 505 21.2 MARKET SIZE ESTIMATION 506 21.2.1 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: SUPPLY SIDE 507 21.2.2 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: DEMAND SIDE 507 21.2.3 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 508 21.2.4 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 510 21.3 DATA TRIANGULATION 511 21.4 RESEARCH ASSUMPTIONS 512 21.5 RESEARCH LIMITATIONS 512 22 ADJACENT & RELATED MARKETS 513 22.1 INTRODUCTION 513 22.2 LIMITATIONS 513 22.3 NUTRACEUTICAL INGREDIENTS MARKET 514 22.3.1 MARKET DEFINITION 514 22.3.2 MARKET OVERVIEW 514 22.4 DIETARY SUPPLEMENTS MARKET 515 22.4.1 MARKET DEFINITION 515 22.4.2 MARKET OVERVIEW 515 23 APPENDIX 517 23.1 DISCUSSION GUIDE 517 23.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 525 23.3 CUSTOMIZATION OPTIONS 527 23.4 RELATED REPORTS 527 23.5 AUTHOR DETAILS 528
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES, 2020–2024 53 TABLE 2 IMPACT OF PORTER’S FIVE FORCES NUTRACEUTICAL GUMMIES MARKET 81 TABLE 3 NUTRACEUTICAL GUMMIES MARKET: SUPPLY CHAIN (ECOSYSTEM) 91 TABLE 4 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER, 2023 (USD/UNIT) 92 TABLE 5 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021–2024 (USD/TON) 95 TABLE 6 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2024 97 TABLE 7 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2023 97 TABLE 8 NUTRACEUTICAL GUMMIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 98 TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES 103 TABLE 10 PATENTS PERTAINING TO NUTRACEUTICAL GUMMIES, 2019–2025 113 TABLE 11 TOP USE CASES AND MARKET POTENTIAL 118 TABLE 12 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 119 TABLE 13 NUTRACEUTICAL GUMMIES MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 119 TABLE 14 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 120 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122 TABLE 18 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123 TABLE 19 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123 TABLE 20 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL GUMMIES MARKET 124 TABLE 21 LABELING REQUIREMENTS AND CLAIMS IN NUTRACEUTICAL GUMMIES MARKET 124 TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN NUTRACEUTICAL GUMMIES MARKET 128 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES 131 TABLE 24 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 131 TABLE 25 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET, BY KEY INDUSTRIES ACROSS SUPPLY CHAIN 133 TABLE 26 COST DYNAMICS IN NUTRACEUTICAL GUMMIES MARKET 135 TABLE 27 MARGIN OPPORTUNITIES IN NUTRACEUTICAL GUMMIES MARKET, BY TYPE 136 TABLE 28 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 138 TABLE 29 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 138 TABLE 30 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (TONS) 138 TABLE 31 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (TONS) 138 TABLE 32 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 141 TABLE 33 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 142 TABLE 34 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 144 TABLE 35 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 145 TABLE 36 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 146 TABLE 37 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 147 TABLE 38 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 149 TABLE 39 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 149 TABLE 40 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 151 TABLE 41 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 151 TABLE 42 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 153 TABLE 43 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 153 TABLE 44 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 155 TABLE 45 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 156 TABLE 46 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 157 TABLE 47 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 157 TABLE 48 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 158 TABLE 49 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 158 TABLE 50 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 159 TABLE 51 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 160 TABLE 52 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 163 TABLE 53 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 163 TABLE 54 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 164 TABLE 55 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 165 TABLE 56 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 166 TABLE 57 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 167 TABLE 58 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 168 TABLE 59 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 169 TABLE 60 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 170 TABLE 61 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 171 TABLE 62 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 174 TABLE 63 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 174 TABLE 64 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 175 TABLE 65 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 175 TABLE 66 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 176 TABLE 67 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 176 TABLE 68 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 177 TABLE 69 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 177 TABLE 70 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 178 TABLE 71 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 178 TABLE 72 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 181 TABLE 73 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 181 TABLE 74 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 182 TABLE 75 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 182 TABLE 76 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 182 TABLE 77 VITAMIN GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 183 TABLE 78 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 183 TABLE 79 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 184 TABLE 80 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 184 TABLE 81 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 185 TABLE 82 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 185 TABLE 83 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 186 TABLE 84 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 187 TABLE 85 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 187 TABLE 86 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 188 TABLE 87 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 188 TABLE 88 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 189 TABLE 89 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 190 TABLE 90 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 190 TABLE 91 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 190 TABLE 92 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 191 TABLE 93 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 191 TABLE 94 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 192 TABLE 95 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 192 TABLE 96 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 192 TABLE 97 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 193 TABLE 98 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 193 TABLE 99 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 194 TABLE 100 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 195 TABLE 101 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 196 TABLE 102 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 197 TABLE 103 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 197 TABLE 104 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 198 TABLE 105 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 199 TABLE 106 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 199 TABLE 107 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 200 TABLE 108 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 200 TABLE 109 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 200 TABLE 110 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 201 TABLE 111 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 201 TABLE 112 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 202 TABLE 113 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 202 TABLE 114 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 203 TABLE 115 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 203 TABLE 116 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 204 TABLE 117 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 204 TABLE 118 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 205 TABLE 119 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 205 TABLE 120 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 206 TABLE 121 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 206 TABLE 122 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 207 TABLE 123 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 207 TABLE 124 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 208 TABLE 125 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 208 TABLE 126 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 210 TABLE 127 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 211 TABLE 128 IMMUNITY SUPPORT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 211 TABLE 129 IMMUNITY SUPPORT GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 212 TABLE 130 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 213 TABLE 131 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 213 TABLE 132 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 214 TABLE 133 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 214 TABLE 134 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 215 TABLE 135 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 216 TABLE 136 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 216 TABLE 137 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 217 TABLE 138 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 217 TABLE 139 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 218 TABLE 140 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 221 TABLE 141 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 221 TABLE 142 GENERATION ALPHA (0–12 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 222 TABLE 143 GENERATION ALPHA (0–12 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 222 TABLE 144 GENERATION Z (13–28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 223 TABLE 145 GENERATION Z (13–28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 223 TABLE 146 MILLENNIALS (29–44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 224 TABLE 147 MILLENNIALS (29–44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 225 TABLE 148 GENERATION X (45–60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 225 TABLE 149 GENERATION X (45–60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 226 TABLE 150 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 227 TABLE 151 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 227 TABLE 152 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 229 TABLE 153 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 230 TABLE 154 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 230 TABLE 155 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 231 TABLE 156 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021–2024 (USD MILLION) 231 TABLE 157 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025–2030 (USD MILLION) 231 TABLE 158 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 232 TABLE 159 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 232 TABLE 160 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 233 TABLE 161 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 233 TABLE 162 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 234 TABLE 163 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 234 TABLE 164 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 235 TABLE 165 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 235 TABLE 166 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 236 TABLE 167 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 236 TABLE 168 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 237 TABLE 169 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 238 TABLE 170 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 241 TABLE 171 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 242 TABLE 172 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 242 TABLE 173 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 242 TABLE 174 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 243 TABLE 175 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 243 TABLE 176 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 243 TABLE 177 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 244 TABLE 178 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 245 TABLE 179 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 246 TABLE 180 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 246 TABLE 181 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 246 TABLE 182 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 246 TABLE 183 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 247 TABLE 184 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 247 TABLE 185 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 247 TABLE 186 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 248 TABLE 187 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 248 TABLE 188 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 248 TABLE 189 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 249 TABLE 190 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 249 TABLE 191 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 249 TABLE 192 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 250 TABLE 193 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 250 TABLE 194 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 250 TABLE 195 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 251 TABLE 196 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 251 TABLE 197 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 251 TABLE 198 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 252 TABLE 199 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 252 TABLE 200 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 252 TABLE 201 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 253 TABLE 202 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 253 TABLE 203 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 254 TABLE 204 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 254 TABLE 205 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 255 TABLE 206 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION) 255 TABLE 207 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION) 255 TABLE 208 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS) 256 TABLE 209 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS) 256 TABLE 210 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 256 TABLE 211 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 257 TABLE 212 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 257 TABLE 213 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 257 TABLE 214 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION) 258 TABLE 215 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION) 258 TABLE 216 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS) 258 TABLE 217 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS) 259 TABLE 218 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 259 TABLE 219 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 259 TABLE 220 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 259 TABLE 221 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 260 TABLE 222 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 260 TABLE 223 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 260 TABLE 224 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 261 TABLE 225 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 261 TABLE 226 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 261 TABLE 227 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 262 TABLE 228 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 262 TABLE 229 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 262 TABLE 230 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 263 TABLE 231 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 263 TABLE 232 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 263 TABLE 233 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 264 TABLE 234 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 265 TABLE 235 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 265 TABLE 236 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 266 TABLE 237 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 266 TABLE 238 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 268 TABLE 239 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 268 TABLE 240 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 268 TABLE 241 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 269 TABLE 242 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 270 TABLE 243 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 270 TABLE 244 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 270 TABLE 245 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 271 TABLE 246 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 272 TABLE 247 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 272 TABLE 248 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 272 TABLE 249 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 273 TABLE 250 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 273 TABLE 251 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 273 TABLE 252 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 274 TABLE 253 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 274 TABLE 254 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 274 TABLE 255 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 275 TABLE 256 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 275 TABLE 257 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 275 TABLE 258 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 276 TABLE 259 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 276 TABLE 260 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 276 TABLE 261 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 277 TABLE 262 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 277 TABLE 263 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 277 TABLE 264 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 278 TABLE 265 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 278 TABLE 266 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 278 TABLE 267 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 279 TABLE 268 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 279 TABLE 269 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 279 TABLE 270 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 280 TABLE 271 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 280 TABLE 272 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 281 TABLE 273 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 281 TABLE 274 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION) 282 TABLE 275 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION) 282 TABLE 276 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS) 282 TABLE 277 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS) 283 TABLE 278 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 283 TABLE 279 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 283 TABLE 280 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 284 TABLE 281 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 284 TABLE 282 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION) 284 TABLE 283 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION) 285 TABLE 284 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS) 285 TABLE 285 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS) 285 TABLE 286 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 286 TABLE 287 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 286 TABLE 288 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 286 TABLE 289 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 286 TABLE 290 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 287 TABLE 291 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 287 TABLE 292 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 287 TABLE 293 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 288 TABLE 294 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 288 TABLE 295 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 288 TABLE 296 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 289 TABLE 297 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 289 TABLE 298 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 289 TABLE 299 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 290 TABLE 300 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 290 TABLE 301 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 290 TABLE 302 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 292 TABLE 303 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 292 TABLE 304 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 292 TABLE 305 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 293 TABLE 306 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 294 TABLE 307 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 294 TABLE 308 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 295 TABLE 309 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 295 TABLE 310 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 297 TABLE 311 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 297 TABLE 312 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 297 TABLE 313 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 298 TABLE 314 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 299 TABLE 315 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 299 TABLE 316 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 300 TABLE 317 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 300 TABLE 318 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 302 TABLE 319 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 302 TABLE 320 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 302 TABLE 321 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 303 TABLE 322 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 304 TABLE 323 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 304 TABLE 324 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 304 TABLE 325 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 305 TABLE 326 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 306 TABLE 327 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 307 TABLE 328 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 307 TABLE 329 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 307 TABLE 330 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 308 TABLE 331 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 308 TABLE 332 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 308 TABLE 333 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 309 TABLE 334 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 309 TABLE 335 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 309 TABLE 336 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 310 TABLE 337 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 310 TABLE 338 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 310 TABLE 339 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 311 TABLE 340 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 311 TABLE 341 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 311 TABLE 342 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 312 TABLE 343 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 312 TABLE 344 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 312 TABLE 345 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 313 TABLE 346 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 313 TABLE 347 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 313 TABLE 348 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 314 TABLE 349 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 314 TABLE 350 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 314 TABLE 351 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 315 TABLE 352 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 315 TABLE 353 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 316 TABLE 354 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION) 316 TABLE 355 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION) 316 TABLE 356 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS) 317 TABLE 357 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS) 317 TABLE 358 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 317 TABLE 359 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 318 TABLE 360 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 318 TABLE 361 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 318 TABLE 362 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION) 319 TABLE 363 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION) 319 TABLE 364 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS) 319 TABLE 365 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS) 320 TABLE 366 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 320 TABLE 367 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 320 TABLE 368 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 320 TABLE 369 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 321 TABLE 370 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 321 TABLE 371 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 321 TABLE 372 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 322 TABLE 373 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 322 TABLE 374 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 322 TABLE 375 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 323 TABLE 376 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 323 TABLE 377 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 323 TABLE 378 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 324 TABLE 379 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 324 TABLE 380 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 324 TABLE 381 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 325 TABLE 382 CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 326 TABLE 383 CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 326 TABLE 384 CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 327 TABLE 385 CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 327 TABLE 386 JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 329 TABLE 387 JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 329 TABLE 388 JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 329 TABLE 389 JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 330 TABLE 390 INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 331 TABLE 391 INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 331 TABLE 392 INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 332 TABLE 393 INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 332 TABLE 394 AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 334 TABLE 395 AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 334 TABLE 396 AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 335 TABLE 397 AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 335 TABLE 398 REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 336 TABLE 399 REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 337 TABLE 400 REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 337 TABLE 401 REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 338 TABLE 402 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 339 TABLE 403 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 339 TABLE 404 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 339 TABLE 405 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 340 TABLE 406 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 340 TABLE 407 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 340 TABLE 408 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021–2024 (TONS) 340 TABLE 409 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025–2030 (TONS) 341 TABLE 410 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 341 TABLE 411 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 341 TABLE 412 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 342 TABLE 413 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 342 TABLE 414 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 342 TABLE 415 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 343 TABLE 416 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 343 TABLE 417 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 343 TABLE 418 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 344 TABLE 419 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 344 TABLE 420 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 344 TABLE 421 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 345 TABLE 422 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 345 TABLE 423 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 345 TABLE 424 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 346 TABLE 425 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 346 TABLE 426 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 346 TABLE 427 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 347 TABLE 428 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 347 TABLE 429 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 348 TABLE 430 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION) 348 TABLE 431 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION) 348 TABLE 432 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS) 349 TABLE 433 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS) 349 TABLE 434 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 349 TABLE 435 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 350 TABLE 436 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 350 TABLE 437 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 350 TABLE 438 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION) 351 TABLE 439 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION) 351 TABLE 440 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS) 351 TABLE 441 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS) 352 TABLE 442 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 352 TABLE 443 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 352 TABLE 444 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 352 TABLE 445 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 353 TABLE 446 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 353 TABLE 447 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 353 TABLE 448 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 354 TABLE 449 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 354 TABLE 450 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 354 TABLE 451 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 355 TABLE 452 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 355 TABLE 453 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 355 TABLE 454 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 356 TABLE 455 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 356 TABLE 456 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 356 TABLE 457 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 357 TABLE 458 BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 358 TABLE 459 BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 358 TABLE 460 BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 359 TABLE 461 BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 359 TABLE 462 ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 360 TABLE 463 ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 361 TABLE 464 ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 361 TABLE 465 ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 362 TABLE 466 REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 363 TABLE 467 REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 363 TABLE 468 REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 363 TABLE 469 REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 364 TABLE 470 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 364 TABLE 471 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 365 TABLE 472 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 365 TABLE 473 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 365 TABLE 474 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (USD MILLION) 365 TABLE 475 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (USD MILLION) 366 TABLE 476 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021–2024 (TONS) 366 TABLE 477 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025–2030 (TONS) 366 TABLE 478 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (USD MILLION) 366 TABLE 479 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (USD MILLION) 367 TABLE 480 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021–2024 (TONS) 367 TABLE 481 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025–2030 (TONS) 367 TABLE 482 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 368 TABLE 483 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 368 TABLE 484 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (TONS) 368 TABLE 485 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (TONS) 369 TABLE 486 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (USD MILLION) 369 TABLE 487 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (USD MILLION) 369 TABLE 488 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021–2024 (TONS) 370 TABLE 489 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025–2030 (TONS) 370 TABLE 490 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (USD MILLION) 370 TABLE 491 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (USD MILLION) 371 TABLE 492 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021–2024 (TONS) 371 TABLE 493 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025–2030 (TONS) 371 TABLE 494 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 372 TABLE 495 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 372 TABLE 496 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (TONS) 373 TABLE 497 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (TONS) 373 TABLE 498 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (USD MILLION) 374 TABLE 499 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (USD MILLION) 374 TABLE 500 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021–2024 (TONS) 374 TABLE 501 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025–2030 (TONS) 375 TABLE 502 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (USD MILLION) 375 TABLE 503 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (USD MILLION) 375 TABLE 504 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021–2024 (TONS) 376 TABLE 505 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025–2030 (TONS) 376 TABLE 506 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (USD MILLION) 376 TABLE 507 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (USD MILLION) 377 TABLE 508 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021–2024 (TONS) 377 TABLE 509 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025–2030 (TONS) 377 TABLE 510 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 378 TABLE 511 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 378 TABLE 512 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021–2024 (TONS) 378 TABLE 513 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025–2030 (TONS) 378 TABLE 514 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (USD MILLION) 379 TABLE 515 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (USD MILLION) 379 TABLE 516 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021–2024 (TONS) 379 TABLE 517 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025–2030 (TONS) 380 TABLE 518 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (USD MILLION) 380 TABLE 519 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (USD MILLION) 380 TABLE 520 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021–2024 (TONS) 381 TABLE 521 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025–2030 (TONS) 381 TABLE 522 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (USD MILLION) 381 TABLE 523 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION) 382 TABLE 524 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021–2024 (TONS) 382 TABLE 525 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025–2030 (TONS) 382 TABLE 526 MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 384 TABLE 527 MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 384 TABLE 528 MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 385 TABLE 529 MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 385 TABLE 530 AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021–2024 (USD MILLION) 386 TABLE 531 AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025–2030 (USD MILLION) 387 TABLE 532 AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021–2024 (USD MILLION) 387 TABLE 533 AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025–2030 (USD MILLION) 388 TABLE 534 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL GUMMIES MARKET, 2020–2025 390 TABLE 535 B2C NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024 393 TABLE 536 B2B NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024 395 TABLE 537 B2C NUTRACEUTICAL GUMMIES MARKET: REGIONAL FOOTPRINT 401 TABLE 538 B2C NUTRACEUTICAL GUMMIES MARKET: PRODUCT TYPE FOOTPRINT 402 TABLE 539 B2C NUTRACEUTICAL GUMMIES MARKET: FUNCTIONALITY FOOTPRINT 403 TABLE 541 NUTRACEUTICAL GUMMIES MARKET: COMPETITIVE BENCHMARKING OF B2B COMPANIES 407 TABLE 542 NUTRACEUTICAL GUMMIES MARKET: PRODUCT LAUNCHES, 2020– OCTOBER 2025 409 TABLE 543 NUTRACEUTICAL GUMMIES MARKET: DEALS, 2020–OCTOBER 2025 413 TABLE 544 NUTRACEUTICAL GUMMIES MARKET: EXPANSIONS, 2020–OCTOBER 2025 416 TABLE 545 NUTRACEUTICAL GUMMIES MARKET: OTHER DEVELOPMENTS, 2020– OCTOBER 2025 418 TABLE 546 CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW 419 TABLE 547 CHURCH & DWIGHT CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 420 TABLE 548 CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES 421 TABLE 549 H&H GROUP: COMPANY OVERVIEW 423 TABLE 550 H&H GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 424 TABLE 551 H&H GROUP: DEALS 425 TABLE 552 H&H GROUP: EXPANSIONS 426 TABLE 553 H&H GROUP: OTHER DEVELOPMENTS 426 TABLE 554 AMWAY: COMPANY OVERVIEW 428 TABLE 555 AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 429 TABLE 556 AMWAY: PRODUCT LAUNCHES 430 TABLE 557 AMWAY: DEALS 431 TABLE 558 BAYER AG: COMPANY OVERVIEW 432 TABLE 559 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 433 TABLE 560 BAYER AG: PRODUCT LAUNCHES 435 TABLE 561 HALEON GROUP OF COMPANIES: COMPANY OVERVIEW 436 TABLE 562 HALEON GROUP OF COMPANIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 437 TABLE 563 HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES 439 TABLE 564 HALEON GROUP OF COMPANIES: DEALS 440 TABLE 565 HALEON GROUP OF COMPANIES: EXPANSIONS 440 TABLE 566 NESTLE: COMPANY OVERVIEW 442 TABLE 567 NESTLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 443 TABLE 568 NESTLE: PRODUCT LAUNCHES 445 TABLE 569 NESTLE: DEALS 445 TABLE 570 UNILEVER: COMPANY OVERVIEW 447 TABLE 571 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 448 TABLE 572 UNILEVER: PRODUCT LAUNCHES 449 TABLE 573 UNILEVER: DEALS 449 TABLE 574 UNILEVER: EXPANSIONS 450 TABLE 575 OTSUKA HOLDINGS CO., LTD.: COMPANY OVERVIEW 451 TABLE 576 OTSUKA HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 452 TABLE 577 OTSUKA HOLDINGS CO., LTD.: PRODUCT LAUNCHES 453 TABLE 578 OTSUKA HOLDINGS CO., LTD.: EXPANSIONS 454 TABLE 579 PHARMACARE LABORATORIES: COMPANY OVERVIEW 456 TABLE 580 PHARMACARE LABORATORIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 456 TABLE 581 PHARMACARE LABORATORIES: EXPANSIONS 457 TABLE 582 SWANSON: COMPANY OVERVIEW 459 TABLE 583 SWANSON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 459 TABLE 584 SWANSON: PRODUCT LAUNCHES 460 TABLE 585 IM HEALTHCARE: COMPANY OVERVIEW 461 TABLE 586 IM HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 461 TABLE 587 SMP NUTRA: COMPANY OVERVIEW 463 TABLE 588 SMP NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 463 TABLE 589 NATURE’S TRUTH: COMPANY OVERVIEW 465 TABLE 590 NATURE’S TRUTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 465 TABLE 591 NATURE’S TRUTH: OTHER DEVELOPMENTS 466 TABLE 592 HERBALAND NATURALS INC.: COMPANY OVERVIEW 467 TABLE 593 HERBALAND NATURALS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 467 TABLE 594 BOSCOGEN, INC.: COMPANY OVERVIEW 469 TABLE 595 BOSCOGEN, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 469 TABLE 596 SOFGEN PHARMA: COMPANY OVERVIEW 470 TABLE 597 SOFGEN PHARMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 471 TABLE 598 SOFGEN PHARMA: EXPANSIONS 472 TABLE 599 CATALENT, INC.: COMPANY OVERVIEW 474 TABLE 600 CATALENT, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 474 TABLE 601 CATALENT, INC.: DEALS 475 TABLE 602 ACTIV'INSIDE: COMPANY OVERVIEW 476 TABLE 603 ACTIV'INSIDE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 476 TABLE 604 SIRIO PHARMA CO., LTD.: COMPANY OVERVIEW 478 TABLE 605 SIRIO PHARMA CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 479 TABLE 606 SIRIO PHARMA CO., LTD.: PRODUCT LAUNCHES 480 TABLE 607 WIN NUTRA: COMPANY OVERVIEW 481 TABLE 608 WIN NUTRA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 481 TABLE 609 MAKERS NUTRITION, LLC.: COMPANY OVERVIEW 483 TABLE 610 MAKERS NUTRITION, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 484 TABLE 611 ION LABS: COMPANY OVERVIEW 486 TABLE 612 ION LABS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 487 TABLE 613 ION LABS: EXPANSIONS 487 TABLE 614 ION LABS: DEALS 488 TABLE 615 VITAJOY GROUP: COMPANY OVERVIEW 489 TABLE 616 VITAJOY GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 490 TABLE 617 BLISS LIFESCIENCES LLP: COMPANY OVERVIEW 491 TABLE 618 BLISS LIFESCIENCES LLP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 491 TABLE 619 GLOBAL WIDGET: COMPANY OVERVIEW 493 TABLE 620 GLOBAL WIDGET: PRODUCTS/SERVICES/SOLUTIONS OFFERED 494 TABLE 621 GLOBAL WIDGET: PRODUCT LAUNCHES 495 TABLE 622 GLOBAL WIDGET: DEALS 496 TABLE 623 GLOBAL WIDGET: EXPANSIONS 496 TABLE 624 ADJACENT MARKETS TO NUTRACEUTICAL GUMMIES MARKET 513 TABLE 625 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 514 TABLE 626 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 515 TABLE 627 DIETARY SUPPLEMENTS MARKET, BY REGION, 2020–2023 (USD MILLION) 516 TABLE 628 DIETARY SUPPLEMENTS MARKET, BY REGION, 2024–2029 (USD MILLION) 516 FIGURE 1 NUTRACEUTICAL GUMMIES MARKET SEGMENTATION 52 FIGURE 2 YEARS CONSIDERED 53 FIGURE 3 MARKET SCENARIO 55 FIGURE 4 B2C NUTRACEUTICAL GUMMIES MARKET, 2021–2030 56 FIGURE 5 B2B NUTRACEUTICAL GUMMIES MARKET, 2021-2030 56 FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN B2C NUTRACEUTICAL GUMMIES MARKET (2020–2025) 57 FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF NUTRACEUTICAL GUMMIES MARKET 58 FIGURE 8 HIGH-GROWTH SEGMENTS IN B2C NUTRACEUTICAL GUMMIES MARKET 59 FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN B2C NUTRACEUTICAL GUMMIES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 60 FIGURE 10 FOCUS ON CONTRACT MANUFACTURING, SCALE EFFICIENCY, AND INGREDIENT AVAILABILITY TO DRIVE B2B NUTRACEUTICAL GUMMIES MARKET 61 FIGURE 11 RISING CONSUMER PREFERENCE FOR CONVENIENT, FUNCTIONAL, AND PALATABLE SUPPLEMENTS TO DRIVE B2C NUTRACEUTICAL GUMMIES MARKET 61 FIGURE 12 MID-SCALE MANUFACTURERS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025 62 FIGURE 13 VITAMINS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025 63 FIGURE 14 BRAND OWNERS & MARKETING COMPANIES SEGMENT TO DOMINATE MARKET IN 2025 63 FIGURE 15 ANIMAL-BASED SOURCES SEGMENT TO LEAD MARKET IN 2025 64 FIGURE 16 GENERATION Z SEGMENT TO LEAD MARKET IN 2025 64 FIGURE 17 US TO DOMINATE MARKET IN 2025 65 FIGURE 18 US TO DOMINATE MARKET IN 2025 65 FIGURE 19 NUTRACEUTICAL GUMMIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67 FIGURE 20 NUTRACEUTICAL GUMMIES MARKET: PORTER’S FIVE FORCES ANALYSIS 81 FIGURE 21 NUTRACEUTICAL GUMMIES (B2B & B2C) MARKET: VALUE CHAIN ANALYSIS 87 FIGURE 22 NUTRACEUTICAL GUMMIES MARKET: ECOSYSTEM ANALYSIS 90 FIGURE 23 AVERAGE SELLING PRICE OF MARKET PLAYERS, BY PRODUCT TYPES, 2024 (USD/TON) 92 FIGURE 24 AVERAGE SELLING PRICE TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021–2024 (USD/TON) 95 FIGURE 25 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT) 96 FIGURE 26 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020–2024 (MT) 96 FIGURE 27 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 99 FIGURE 28 INVESTMENT AND FUNDING SCENARIO 99 FIGURE 29 NUMBER OF PATENTS GRANTED BETWEEN 2015 AND 2025 112 FIGURE 30 FUTURE APPLICATIONS 114 FIGURE 31 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET 118 FIGURE 32 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 120 FIGURE 33 NUTRACEUTICAL GUMMIES MARKET DECISION-MAKING FACTORS 129 FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES 130 FIGURE 35 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 131 FIGURE 36 ADOPTION BARRIERS AND INTERNAL CHALLENGES 132 FIGURE 37 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025 VS. 2030 (USD MILLION) 141 FIGURE 38 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025 VS. 2030 (USD MILLION) 155 FIGURE 39 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025 VS. 2030 (USD MILLION) 162 FIGURE 40 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025 VS. 2030 (USD MILLION) 173 FIGURE 48 REVENUE ANALYSIS OF B2C MARKET PLAYERS, 2022–2024 (USD MILLION) 391 FIGURE 49 SHARE ANALYSIS FOR B2C MARKET PLAYERS, 2024 392 FIGURE 50 SHARE ANALYSIS FOR B2B MARKET PLAYERS, 2024 395 FIGURE 51 NUTRACEUTICAL GUMMIES MARKET: BRAND/PRODUCT COMPARISON 396 FIGURE 52 NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX (B2C COMPANIES), 2024 399 FIGURE 53 B2C NUTRACEUTICAL GUMMIES MARKET: COMPANY FOOTPRINT 400 FIGURE 54 NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX (B2B COMPANIES), 2024 405 FIGURE 55 COMPANY VALUATION FOR MAJOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET 408 FIGURE 56 EV/EBITDA OF MAJOR PLAYERS 409 FIGURE 57 CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT 420 FIGURE 58 H&H GROUP: COMPANY SNAPSHOT 424 FIGURE 59 AMWAY: COMPANY SNAPSHOT 428 FIGURE 60 BAYER AG: COMPANY SNAPSHOT 433 FIGURE 61 HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT 437 FIGURE 62 NESTLE: COMPANY SNAPSHOT 443 FIGURE 63 UNILEVER: COMPANY SNAPSHOT 448 FIGURE 64 OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT 452 FIGURE 65 SOFGEN PHARMA: COMPANY SNAPSHOT 471 FIGURE 66 SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT 479 FIGURE 67 NUTRACEUTICAL GUMMIES MARKET: RESEARCH DESIGN 502 FIGURE 68 KEY INDUSTRY INSIGHTS 504 FIGURE 69 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION 505 FIGURE 70 SUPPLY-SIDE ANALYSIS 507 FIGURE 71 DEMAND-SIDE ANALYSIS 507 FIGURE 72 B2C NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH 508 FIGURE 73 B2B NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH 509 FIGURE 74 NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: TOP-DOWN APPROACH 510 FIGURE 75 DATA TRIANGULATION METHODOLOGY 511 FIGURE 76 ASSUMPTIONS 512 FIGURE 77 STUDY LIMITATIONS AND RISK ASSESSMENT 512

同分類最新報告（食品與飲料）

查看食品與飲料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們